Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients.
BACKGROUND: MicroRNAs (miRNAs) are small ribonucleotides regulating gene expression. MicroRNAs are present in the blood in a remarkably stable form and have emerged as potential diagnostic markers in patients with cardiovascular disease. Our study aimed to assess circulating miR-133a levels in MHD p...
Main Authors: | Ping Wen, Dan Song, Hong Ye, Xiaochun Wu, Lei Jiang, Bing Tang, Yang Zhou, Li Fang, Hongdi Cao, Weichun He, Yafang Yang, Chunsun Dai, Junwei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4196728?pdf=render |
Similar Items
-
Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
by: Xiong Zhang, et al.
Published: (2017-06-01) -
MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis.
by: Yang Wang, et al.
Published: (2012-01-01) -
Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients.
by: Hongdi Cao, et al.
Published: (2014-01-01) -
The Changes Of Heart MiR-1 And MiR-133 Expressions Following Physiological Hypertrophy Due To Endurance Training
by: Mohammad Fathi, et al.
Published: (2020-09-01) -
A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C.
by: Hongdi Cao, et al.
Published: (2013-01-01)